The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2)

Kruppel-Like Factor 2 Is a Transcriptional Regulator of Chronic and Acute Inflammation

(2013) Lalitha Nayak et al.   AMERICAN JOURNAL OF PATHOLOGY

Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function

(2013) Hong Shi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice

(2012) Guangjin Zhou et al.   JOURNAL OF CLINICAL INVESTIGATION

The Myeloid Transcription Factor KLF2 Regulates the Host Response to Polymicrobial Infection and Endotoxic Shock

(2011) Ganapati H. Mahabeleshwar et al.   IMMUNITY

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

(2010) S. Y. Kristinsson et al.   BLOOD

Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma

(2010) Yunfeng Shen et al.   LEUKEMIA RESEARCH

Mammalian Krüppel-Like Factors in Health and Diseases

(2010) Beth B. McConnell et al.   PHYSIOLOGICAL REVIEWS

Combination Treatment With VELCADE and Low-Dose Tissue Plasminogen Activator Provides Potent Neuroprotection in Aged Rats After Embolic Focal Ischemia

(2010) Li Zhang et al.   STROKE

Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Krüppel-Like Transcription Factors

(2009) Toyoko Hiroi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

(2009) Sundar Jagannath et al.   BRITISH JOURNAL OF HAEMATOLOGY

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

(2009) Alok A. Khorana et al.   JOURNAL OF CLINICAL ONCOLOGY

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma

(2008) A. Palumbo et al.   ANNALS OF ONCOLOGY

Platelet-Monocyte Interactions - A Dangerous Liaison Linking Thrombosis, Inflammation and Atherosclerosis

(2008) Peter Seizer et al.   CURRENT MEDICINAL CHEMISTRY

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma

(2008) M. Zangari et al.   HAEMATOLOGICA

Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro

(2007) Ferit Avcu et al.   THROMBOSIS RESEARCH